Medical Research
Inside the Urgent Race for a Remedy Against Congo’s Deadliest Ebola Outbreak
More than 250 people have entered a closely monitored trial testing whether Gilead’s experimental antiviral pill can prevent Ebola after exposure as Congo struggles with a Bundibugyo virus outbreak that has killed 4,000 people.